US Patent Issued to Board of Regents, The University of Texas System on Oct. 27 for "Peptide-based compositions and methods for treating Alzheimer's disease" (Polish, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,304, issued on Oct. 27, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Peptide-based compositions and methods for treating Alzheimer's disease" was invented by Pawel A. Osmulski (San Antonio), Maria Gaczynska (San Antonio), Andrew Pickering (San Antonio), Przemyslaw Karpowicz (Gdansk, Poland) and Elzbieta Jankowska (Gdansk, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, are peptides capable of activating proteasome activity, and pharmaceutical compositions containing the peptides and methods treating Alzheimer's disease. Disclosed herein are compositions comprising: A) a peptide, wherein t...